693 related articles for article (PubMed ID: 30563866)
1. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
[TBL] [Abstract][Full Text] [Related]
2. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis.
Yang Y; Huang Z; Zhang X
Medicine (Baltimore); 2021 Dec; 100(50):e27804. PubMed ID: 34918630
[TBL] [Abstract][Full Text] [Related]
4. Aspirin plus clopidogrel
Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
[No Abstract] [Full Text] [Related]
5. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
Squizzato A; Bellesini M; Takeda A; Middeldorp S; Donadini MP
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005158. PubMed ID: 29240976
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
[TBL] [Abstract][Full Text] [Related]
7. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
[TBL] [Abstract][Full Text] [Related]
8. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
Naqvi IA; Kamal AK; Rehman H
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009716. PubMed ID: 32813275
[TBL] [Abstract][Full Text] [Related]
9. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
Prasad K; Siemieniuk R; Hao Q; Guyatt G; O'Donnell M; Lytvyn L; Heen AF; Agoritsas T; Vandvik PO; Gorthi SP; Fisch L; Jusufovic M; Muller J; Booth B; Horton E; Fraiz A; Siemieniuk J; Fobuzi AC; Katragunta N; Rochwerg B
BMJ; 2018 Dec; 363():k5130. PubMed ID: 30563885
[TBL] [Abstract][Full Text] [Related]
10. Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial.
Zhang XG; Zhu XQ; Xue J; Li ZZ; Jiang HY; Hu L; Yue YH
BMJ Open; 2019 May; 9(5):e028595. PubMed ID: 31123001
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES).
Gao Y; Pan Y; Han S; Chen W; Jing J; Wang C; Yang Y; Wang T; Meng X; Zhao X; Liu L; Li H; Johnston SC; Amarenco P; Bath PM; Wang Y; Wang Y;
Stroke Vasc Neurol; 2023 Jun; 8(3):249-258. PubMed ID: 36707080
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
[TBL] [Abstract][Full Text] [Related]
14. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
[TBL] [Abstract][Full Text] [Related]
17. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.
Gao Y; Chen W; Pan Y; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Jiang L; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y;
N Engl J Med; 2023 Dec; 389(26):2413-2424. PubMed ID: 38157499
[TBL] [Abstract][Full Text] [Related]
18. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Shah J; Liu S; Yu W
Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
[TBL] [Abstract][Full Text] [Related]
19. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
